French microLED display startup Aledia announced it closed an €80M first tranche of its €120M D-round financing. The company will reportedly use the funds to finish product development and create a new high-volume 3D microLED manufacturing facility in France for an estimated capital expenditure of €40 million (excluding equipment).

Aledia uses its proprietary technology to generate LED chips for next-generation displays for smartphones, laptops, smartwatches, tablets, augmented-reality glasses and large TVs.  The technology is reportedly the subject of 197 patent families making Aledia the top French startup in France in terms of filed patents.

Aledia investors reportedly include Demeter Investment Partners, Ingka Investments, Braemar Energy Ventures, the Ecotechnologies fund of Bpifrance, Supernova Invest, Valeo, Intel Capital, Sofinnova Ventures, TEL (Tokyo Electron), and several large technology companies.

See Business Wire; Yahoo Finance

 

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Dan Shores Dan Shores

Dan Shores is a partner at  Rothwell, Figg and founder of its Boston office. He serves companies operating in dynamic biotech and other markets building patent portfolios, litigating complex patent disputes, negotiating strategic collaborations, and conducting due diligence and landscape investigations. Dan has…

Dan Shores is a partner at  Rothwell, Figg and founder of its Boston office. He serves companies operating in dynamic biotech and other markets building patent portfolios, litigating complex patent disputes, negotiating strategic collaborations, and conducting due diligence and landscape investigations. Dan has served companies utilizing the following technologies (without limitation): mRNA; lipid nanoparticles; CAR-T; oligonucleotides; genetically engineered swine organs for xenotransplantation; artificial intelligence for drug discovery; small molecules; biologics, materials science, and numerous other technologies throughout his 20-year career. Dan has a B.S. in engineering with a specialization in materials science from the University of New Hampshire and a J.D. from the Georgetown University Law Center. He is a registered patent attorney licensed to practice before the United States Patent and Trademark Office, and is admitted to practice law in Massachusetts and in the District of Columbia. He is a member of the bars of the Supreme Court of the United States, United States Court of Appeals for the Federal Circuit, and United States District Court for the District of Massachusetts.

Read more about Dan ShoresDan's Linkedin Profile
Show more Show less
Related Posts
 Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy
April 25, 2025
mRNA2-3-11-25
mRNA/LNP Patent Litigation Update (Q1 2025)
April 9, 2025
4
Key Patent Considerations for Antibody Drug Conjugates (ADCs)
April 8, 2025